Published in
American Chemical Society, ACS Medicinal Chemistry Letters, 5(8), p. 582-586, 2017
DOI: 10.1021/acsmedchemlett.7b00157
Links
Tools
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma
Journal article published in 2017 by
David A. Sandham 
,
Lucy Barker,
Lyndon Brown,
Zarin Brown,
David Budd,
Steven J. Charlton,
Devnandan Chatterjee,
Brian Cox,
Gerald Dubois,
Nicholas Duggan,
Edward Hall,
Julia Hatto,
Janet Maas,
Jodie Manini,
Rachael Profit
and other authors.
,
Lucy Barker,
Lyndon Brown,
Zarin Brown,
David Budd,
Steven J. Charlton,
Devnandan Chatterjee,
Brian Cox,
Gerald Dubois,
Nicholas Duggan,
Edward Hall,
Julia Hatto,
Janet Maas,
Jodie Manini,
Rachael Profit
and other authors.
This paper is available in a repository.
Full text: Download
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 